Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimérism after allogeneic stem cell transplantation
Authors:
O. Hrodek
Published in:
Transfuze Hematol. dnes,18, 2012, No. 1, p. 46.
Category:
Selection of press reports and books
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2012 Issue 1
- Administration of aPCC as a Prevention of Bleeding After Major Cardiac Surgical Procedures
- Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A
- Vascular Disease in the Gradually Aging Population of Hemophiliacs: An Underestimated Problem?
- Prognostic Significance of Subclinical Joint Changes on MRI in Hemophilia
- Immunotolerance is still the goal of management of hemophilia A with inhibitor in the era of non-factor therapy
-
All articles in this issue
- Mobilization of hematopoetic stem cells using plerixafor - experience of the Czech Republic transplantation centers
- Genetic polymorphisms of platelet receptors in young patients with AIM and resistance to antiplatelet therapy
- Venous thrombosis in children with acute lymphoblastic leukaemia
- Prevalence of red blood cell and HLA antibodies in multi-transfused haematological patients
- The role of physical activity in patients suffering from haematological malignancies
- Asymptomatic pituitary macroadenoma oppressing optic chiasm – ‘incidentaloma‘ – identified within diagnostical staging of patient with primary extranodal diffuse large B-cell lymphoma of orbit and paranasal sinuses – a case report
- Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease
- Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol
- Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leukemia as examples (Perspectives)
- Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimérism after allogeneic stem cell transplantation
- Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E. coli asparaginase: a retrospective analysis within the ALL-BFM trials
- Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility (Evidence-based focused review)
- The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study
- VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children
- Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia
- Transfusion and Haematology Today
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Asymptomatic pituitary macroadenoma oppressing optic chiasm – ‘incidentaloma‘ – identified within diagnostical staging of patient with primary extranodal diffuse large B-cell lymphoma of orbit and paranasal sinuses – a case report
- The role of physical activity in patients suffering from haematological malignancies
- Prevalence of red blood cell and HLA antibodies in multi-transfused haematological patients
- Mobilization of hematopoetic stem cells using plerixafor - experience of the Czech Republic transplantation centers